nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Pethidine—SLC6A3—Gilles de la Tourette syndrome	0.102	1	CrCbGaD
Remifentanil—OPRD1—nervous system—Gilles de la Tourette syndrome	0.0796	0.125	CbGeAlD
Remifentanil—OPRD1—central nervous system—Gilles de la Tourette syndrome	0.0766	0.12	CbGeAlD
Remifentanil—OPRK1—nervous system—Gilles de la Tourette syndrome	0.0763	0.119	CbGeAlD
Remifentanil—OPRK1—central nervous system—Gilles de la Tourette syndrome	0.0734	0.115	CbGeAlD
Remifentanil—OPRM1—midbrain—Gilles de la Tourette syndrome	0.066	0.103	CbGeAlD
Remifentanil—OPRD1—brain—Gilles de la Tourette syndrome	0.0608	0.0952	CbGeAlD
Remifentanil—OPRK1—brain—Gilles de la Tourette syndrome	0.0583	0.0913	CbGeAlD
Remifentanil—OPRM1—nervous system—Gilles de la Tourette syndrome	0.0543	0.0849	CbGeAlD
Remifentanil—OPRM1—central nervous system—Gilles de la Tourette syndrome	0.0522	0.0818	CbGeAlD
Remifentanil—OPRM1—brain—Gilles de la Tourette syndrome	0.0415	0.0649	CbGeAlD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0285	0.11	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.025	0.0963	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0211	0.0814	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00505	0.0195	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.0049	0.0189	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00469	0.0181	CbGpPWpGaD
Remifentanil—OPRD1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00457	0.0176	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00455	0.0175	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00443	0.0171	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.0043	0.0166	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00424	0.0163	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00411	0.0158	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00401	0.0155	CbGpPWpGaD
Remifentanil—OPRK1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.004	0.0154	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00399	0.0154	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0039	0.015	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00374	0.0144	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00372	0.0143	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00363	0.014	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00363	0.014	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00352	0.0136	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00347	0.0134	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00342	0.0132	CbGpPWpGaD
Remifentanil—OPRM1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00338	0.0131	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00337	0.013	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00318	0.0123	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00314	0.0121	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00306	0.0118	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00297	0.0115	CbGpPWpGaD
Remifentanil—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00297	0.0114	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00297	0.0114	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00289	0.0111	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00276	0.0107	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00269	0.0104	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00268	0.0103	CbGpPWpGaD
Remifentanil—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0026	0.01	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0026	0.01	CbGpPWpGaD
Remifentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00254	0.00981	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00242	0.00935	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00227	0.00874	CbGpPWpGaD
Remifentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00223	0.0086	CbGpPWpGaD
Remifentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0022	0.00848	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0022	0.00848	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00205	0.0079	CbGpPWpGaD
Remifentanil—OPRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00194	0.00747	CbGpPWpGaD
Remifentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00188	0.00727	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00173	0.00666	CbGpPWpGaD
Remifentanil—OPRK1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.0017	0.00655	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00168	0.00647	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00157	0.00605	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00156	0.00603	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00152	0.00587	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00151	0.00584	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00147	0.00567	CbGpPWpGaD
Remifentanil—OPRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00143	0.00553	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00142	0.00547	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00138	0.00531	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00137	0.00528	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00134	0.00515	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00128	0.00494	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00124	0.0048	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00124	0.00479	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00116	0.00448	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00116	0.00447	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00113	0.00435	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00109	0.00422	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00105	0.00405	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000994	0.00383	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000959	0.0037	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000927	0.00357	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.0009	0.00347	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000871	0.00336	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000838	0.00323	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000813	0.00313	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000811	0.00313	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000789	0.00304	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000736	0.00284	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000735	0.00283	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000687	0.00265	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000667	0.00257	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000621	0.0024	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000587	0.00226	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000515	0.00199	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000435	0.00168	CbGpPWpGaD
